The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Gritstone Oncology, Inc(NASDAQ:GRTS) 
Gritstone Oncology, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, includi...
Website: http://gritstoneoncology.com
Founded: 2015
Full Time Employees: 177
Sector: Healthcare
Industry: Biotechnology
Gritstone Oncology Days Payable Outstanding ttm (DPO)
Gritstone Oncology Days Receivable Outstanding ttm (DSO)
Gritstone Oncology Days Inventory Outstanding ttm (DIO)
Gritstone Oncology Op Cashflow Per Share ttm
Gritstone Oncology Free Cashflow Per Share ttm
Gritstone Oncology Cash Per Share ttm
Gritstone Oncology P/S ratio ttm
Gritstone Oncology (GAAP) P/E ratio ttm
Gritstone Oncology P/B ratio ttm
No extra charts and metrics for this ticker.